Navigation Links
FDA Tentatively Approves Intelliject's Lead Product, e-cue™
Date:8/1/2011

y will offer superior solutions. The company only proceeds to an active development program once it has established that incremental clinical and economic benefit is achievable.

Intelliject is a privately-held company headquartered in Richmond, Virginia.

For online information please visit www.intelliject.com.

About anaphylaxis

Anaphylaxis is a severe allergic reaction that involves a number of body systems and can be fatal within minutes. The American College of Allergy, Asthma and Immunology estimates there are up to 2,000 episodes of anaphylaxis per every 100,000 people in the U.S. each year, although the precise incidence of anaphylaxis is unknown and is likely underreported.

Anaphylaxis can occur in people with allergies to certain foods, insect stings, medications, latex or other allergens. All published national anaphylaxis guidelines recommend epinephrine as the first choice treatment in an acute episode. The vast majority of deaths from anaphylaxis occur in individuals who do not receive epinephrine in a timely manner.

Intelliject Disclaimer: In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Intelliject's current expectations or forecasts of future events. These may include statements regarding anticipated development of potential products; interpretation of clinical results; prospects for regulatory approval; manufacturing development and capabilities; market prospects for its products; and other statements regarding matters that are not historical facts. Some of these forward-looking statements may be identified by the use of words in the statements such as "estimate," "intend," or other words and terms of similar meaning. Statements contained in this release are not guarantees of future performance and in
'/>"/>

SOURCE Intelliject, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves New Medicine BRILINTA™ (Ticagrelor) for Use in the US
2. FDA Approves Vaccines for the 2011-2012 Influenza Season
3. FDA Approves Boostrix to Prevent Tetanus, Diphtheria, and Pertussis in Older People
4. FDA Approves Arcapta Neohaler to Treat Chronic Obstructive Pulmonary Disease
5. FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery
6. FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
7. FDA Approves First Generic Versions of the Antibiotic Levofloxacin to Treat Certain Infections
8. FDA Approves Nulojix for Kidney Transplant Patients
9. FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment
10. FDA Approves First Ceramic-on-Metal Total Hip Replacement System
11. FDA Approves Redesigned Labels for Some Merck Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015 Levi & Korsinsky announces it ... OHRP ) concerning possible violations of federal securities ... Company in connection with its study of the drug ... or contact Joseph E. Levi, Esq. ... telephone at (212) 363-7500, toll-free: (877) 363-5972. ...
(Date:3/27/2015)... /PRNewswire/ - Medicure Inc. (the "Company") (TSXV:MPH, OTCQB:MCUJF) announces ... grant of an aggregate of 236,070 options to certain ... the Company pursuant to the Company,s Stock Option Plan. ... the tenth anniversary of the date of grant, 5,000 ... the date of grant and 50,000 are set to ...
(Date:3/27/2015)... /CNW Telbec/ - Russell Williams , President of ... welcomes the 2015-2016 Quebec Budget, noting the fiscal discipline ... biopharmaceutical industry. However, the association is concerned about the ... the government,s intent to strive for a balanced budget ... Quebec,s economic development is encouraging," ...
Breaking Medicine Technology:Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3
... DHAKA, Bangladesh, Feb. 7, 2011 ... million people served by just 11 modern radiotherapy linear ... Varian Medical Systems (NYSE: VAR). Treatments using fast and ... a new Clinac® iX medical linear accelerator at the ...
... 7, 2011 Amarin Corporation plc (Nasdaq: AMRN ... the Leerink Swann Hot Topics in Therapeutics Roundtable Conference on ... discussion on Cardiology at 7:45am ET and a company presentation ... Roosevelt Hotel in New York City. A live ...
Cached Medicine Technology:Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems 2Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems 3Amarin to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference 2
(Date:3/28/2015)... 2015 Purity Products®, a leading ... the release of their revolutionary new weight loss ... randomized, double-blind, placebo-controlled clinical studies to be effective ... size. MuffinStop™ is a combination of two traditionally ... fused together to create one of the most ...
(Date:3/27/2015)... Red Deer, Alberta (PRWEB) March 27, 2015 ... had, until then, prevented her from working, Monica K. arrived ... day in the mending department quiet, defensive and scared. The ... Employment Placement & Support Services (EPSS) to offer jobs ... it does take patience and a willingness to begin with ...
(Date:3/27/2015)... York, NY (PRWEB) March 27, 2015 ... seeing more plastic surgery patients travel to the Dominican ... Medina. The plastic surgery clinic is turning the medical ... international cosmetic surgery patients — with trustworthy services becoming ... factor when selecting a plastic surgeon. Patients are not ...
(Date:3/27/2015)... San Jose, CA (PRWEB) March 27, 2015 ... last week’s 2015 GPU technology conference (GTC) , the ... to fight cancer and push the human lifespan well beyond ... Baltimore MD informatics company , is one of 12 ... , While other startups in the GTC Emerging ...
(Date:3/27/2015)... March 27, 2015 Endure Yoga is ... functional fitness athletes. This new program matches yoga poses ... for post-workout cool down. This program utilizes yoga to ... and mental focus. , Karen Lefurgy, competitive athlete ... yoga long before I started Crossfit® training, but quickly, ...
Breaking Medicine News(10 mins):Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 2Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 3Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:Endure Yoga Introduces WOD Recovery Yoga 2
... The Center for ... with the flu (influenza). On average, the influenza virus leads to 20,000 to 40,000 American ... deaths by offering free flu shots . , ... Plano, TX (Vocus) September 12, 2009 -- Starting Monday, September 14th, the Plano location ...
... Hernandez, Ph.D., M.P.H.an assistant professor at the University of ... that body mass in younger and older adulthood, and ... man,s risk for prostate cancer. This risk varies among ... study published in Cancer Epidemiology, Biomarkers & Prevention ...
... , TAMPA, Fla. and SAN FRANCISCO, Sept. ... agreement to roll out Demandforce D3, a web-based patient communications ... in Florida and Georgia. Coast Dental, the leading dental provider ... pilot. , , Coast Dental integrated the ...
... NEW YORK, Sept. 11 Duane Reade Holdings Inc., ... as the Local Presenting Sponsor of the 2009 Komen New York ... foundation, The Duane Reade Charitable Foundation, have raised $330,000 to increase ... find a cure. This marks the third year that Duane Reade ...
... , LIONVILLE, Pa., Sept. 11 ... that Donald E. Morel, Jr., Ph.D., Chairman and Chief Executive Officer, ... 7th Annual Best Ideas Conference 2009, being held September 16-17, 2009 ... the UBS Global Life Sciences Conference, being held September 21-23, 2009 ...
... ROCHESTER, Minn., Sept. 11 Mayo Clinic researchers ... may help them diagnose cardiac infections without an invasive exam. ... on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco. , ... ) , , Endocarditis -- an infection ...
Cached Medicine News:Health News:H1N1 frenzy may allow regular flu to be more deadly than ever 2Health News:University of Hawaii at Manoa CRCH scientists report adulthood body size associated with cancer risk 2Health News:Coast Dental Deploys Demandforce D3 Communications Platform 2Health News:New Yorkers Help Duane Reade Increase Support of the 19th Annual Komen New York City Race For The Cure(R) 2Health News:New Yorkers Help Duane Reade Increase Support of the 19th Annual Komen New York City Race For The Cure(R) 3Health News:West to Present at Two Upcoming Investor Conferences 2Health News:Artificial Intelligence Helps Diagnose Cardiac Infections 2Health News:Artificial Intelligence Helps Diagnose Cardiac Infections 3
Constructed from soft Shur-grip foam and velcro closure for easy application and - reapplication...
... Cobalt Binding (ACB®) Test is a clinical ... (IMA®) by measuring the cobalt binding capacity ... First identified in the early 1990s, IMA ... contact with ischemic tissue in the heart. ...
... Albumin Cobalt Binding (ACB®) Test is a ... Albumin (IMA®) by measuring the cobalt binding ... sample. First identified in the early 1990s, ... in contact with ischemic tissue in the ...
Our Osteomark® ELISA kits provide a quantitative measurement of cross-linked N-telopeptides of type I collagen (NTx) as an indicator of bone resorption, with higher levels in serum or urine sampl...
Medicine Products: